Download PDFPDF
New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    New BSG guidelines for the diagnosis and managment of Barrett's oesophagus
    • Peter R Watson, Senior Lecturer in Medicine, Consultant Gastroenterologist
    • Other Contributors:
      • Janusz Jankowski, Paul Moayyedi, Stephen Attwood and Hugh Barr

    Dear Editor,

    We read with interest Professor Playford’s critique of the new BSG guidelines for the diagnosis and management of Barrett’s oesophagus in the April edition of Gut (1). He rightly emphasises the dearth of evidence upon which to formulate policy but goes on to mention the prospect of obtaining such data in future from the AspECT trial and an upcoming HTA sponsored trial of the effectiveness of surveil...

    Show More
    Conflict of Interest:
    None declared.